Stock Screener App

Frei -

1.98

0.51% 0.01

Fortress Biotech Inc (FBIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt FBIO? Forum Prognose Aktiensplit

Fortress Biotech Inc Aktie (FBIO) Neueste Nachrichten

Checkpoint Therapeutics Announces Cosibelimab Longer-Term - GlobeNewswire

Fortress Biotech Inc (FBIO) receives a Buy rating from ROTH MKM - Knox Daily

Journey Medical Corporation to Participate in the Lake Street Capital Markets 8th Annual Best Ideas Growth (BIG) Conference - StockTitan

Fortress Biotech Pref A stock hits 52-week low at $6.06 - Investing.com Canada

Fortress Biotech Inc [FBIO] President, CEO & Chairman makes an insider purchase of 5,000 shares worth 37418.0. - Knox Daily

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire

Fortress Biotech to Present at the H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Journey Medical Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Marketscreener.com

Checkpoint Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference - StockTitan

Does Fortress Biotech Inc (FBIO) offer a good opportunity for investors? - SETE News

Fortress Biotech (FBIO) Shows Fast-paced Momentum But Is Still a Bargain Stock - Yahoo Finance

Fortress Biotech, India Fund, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

Long Term Trading Analysis for (FBIOP) - Stock Traders Daily

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - MSN

Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 20, 2024) - GuruFocus.com

Fortress Biotech (STU:CNB1) 9-Day RSI : N/A (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) 14-Day RSI : 43.84 (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) Volatility : 47.06% (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB0.PFD) EBITDA per Share : €0.00 (TTM As of Jun. 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) GF Value Rank : 2 (As of Aug. 18, 2024) - GuruFocus.com

Fortress Biotech, B. Riley Financial, Another 4 Companies Have A High Estimated Dividend Yield - Via News Agency

FBIOP.PFD (Fortress Biotech) EV-to-Revenue : 0.00 (As of Aug. 17, 2024) - GuruFocus.com

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com India

Fortress Biotech (STU:CNB1) Inventory-to-Revenue : 0.68 (As of Jun. 2024) - GuruFocus.com

Fortress Biotech (STU:CNB1) PE Ratio (TTM) : At Loss (As of Aug. 19, 2024) - GuruFocus.com

Fortress Biotech (FRA:CNB1) Cash Flow for Lease Financing : €0.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com Canada

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com Australia

Fortress Biotech stock hits 52-week low at $6.41 amid market shifts - Investing.com UK

Fortress Biotech, Inc. to Post Q3 2024 Earnings of ($0.27) Per Share, Roth Capital Forecasts (NASDAQ:FBIO) - Defense World

Fortress Biotech (NASDAQ:FBIO) Upgraded by StockNews.com to Hold - Defense World

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com India

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com Australia

Understanding the Risks of Investing in Fortress Biotech Inc (FBIO) - Knox Daily

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com Canada

Fortress Biotech: Q2 Earnings Snapshot - Darien Times

Roth/MKM optimistic on Fortress Biotech shares ahead of key drug approvals - Investing.com UK

Fortress Biotech: Q2 Earnings Snapshot - San Antonio Express-News

Fortress Biotech: Q2 Earnings Snapshot - New Haven Register

FBIO Stock Earnings: Fortress Biotech Beats EPS, Beats Revenue for Q2 2024 - InvestorPlace

Fortress Biotech: Q2 Earnings Snapshot - San Francisco Chronicle

Fortress Biotech: Q2 Earnings Snapshot - Thehour.com

Fortress Biotech: Q2 Earnings Snapshot - Houston Chronicle

Fortress Biotech (FBIO) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Fortress Biotech Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewswire

Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates - StockTitan

(FBIOP) Trading Report - Stock Traders Daily

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - GlobeNewswire

Virtu Financial LLC Acquires New Shares in Fortress Biotech, Inc. (NASDAQ:FBIO) - Defense World

Fortress Biotech (NASDAQ:FBIO) Stock Crosses Above 200-Day Moving Average of $1.90 - Defense World

Avenue Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights - StockTitan

FBIO stock rated a Buy by ROTH MKM - Knox Daily

FBIOFortress Biotech, Inc. Latest Stock News & Market Updates - StockTitan

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024 - StockTitan

Journey Medical Corporation to Announce Second Quarter 2024 Financial Results on August 12, 2024 - GlobeNewswire

Fortress Biotech (NASDAQ:FBIO) Rating Lowered to Sell at StockNews.com - Defense World

Fortress Biotech (NASDAQ:FBIO) Stock Quotes, Forecast and News Summary - Benzinga

SEC Form 424B5 filed by Fortress Biotech Inc. - Quantisnow

When the Price of (FBIOP) Talks, People Listen - Stock Traders Daily

A Guide To The Risks Of Investing In Fortress Biotech Inc (FBIO) - Knox Daily

Fortress Biotech Inc (FBIO) Stock: A Year of Market Movement, Down and Up - The InvestChronicle

$26.55

1.28%

$196.11

1.22%

$28.98

9.71%

$69.58

1.94%

$127.27

3.16%

$538.98

0.25%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | Open in MarketWatch | Open in EDGAR | Open in Reuters